Nir Sassi serves as Executive at Indaptus Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Nir Sassi has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 22, 2025 involved receiving (via award) 26,758 shares valued at $54.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 22, 2025 | INDP | $54.3K | Award | 26,758 | $2.03 | Discretionary |
Nir Sassi currently holds 26,758 shares of Indaptus Therapeutics, Inc. (INDP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nir Sassi has been a net neutral trader of INDP stock. They have purchased $0 and sold $0 worth of shares.
Nir Sassi's most recent insider trade was on Dec 22, 2025, when they sold 26,758 shares at $2.03 per share.
Get notified when new Form 4 filings are submitted